$1.02
N/A
Last update: Oct 30, 7:00 AM
Annovis Bio Inc (ANVS) Stock Price, Quote, News & History
ANVSNYSE
Shares of 8x8 Inc (NASDAQ: EGHT) jumped 13.3% in pre-market trading after reporting better-than-expected Q4 results, with adjusted earnings of 11 cents per...
You can purchase shares of Annovis Bio (NYSE:ANVS) through any online brokerage.
Other companies in Annovis Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Annovis Bio has a consensus price target of $27.88.
The stock price for Annovis Bio (NYSE: ANVS) is $1.01 last updated October 30, 2026 at 7:00 AM EDT.
There are no upcoming dividends for Annovis Bio.
Annovis Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Annovis Bio.
Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's...
